Meloxicam Capsule (Meloxicam)

Adult dose

1. Acute exacerbations of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg once daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this drug orally once daily. The dose may be reduced to 7.5 mg once daily according to the response to treatment. This drug should not be administered at doses exceeding 15 mg per day and should be taken with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment should generally be started at a dose of 7.5 mg once daily. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg per day.

This medication may cause gastrointestinal bleeding in individuals who regularly consume more than three alcoholic beverages daily, so it is essential to consult a doctor or pharmacist. This drug can pose risks to the cardiovascular system; therefore, special caution is required for patients at risk for heart disease or stroke, and if chest pain or shortness of breath occurs, discontinuation should be immediate. This medication can cause severe gastrointestinal issues such as bleeding, ulceration, or perforation, and should be used with greater caution in patients with a history of gastrointestinal diseases or in the elderly. Severe allergic reactions or dermatitis may develop on the skin, so if abnormal skin symptoms occur, discontinue use immediately and consult healthcare professionals. This medication may affect kidney function, so patients with renal diseases or a history of hypertension or heart failure should periodically monitor kidney function before and during medication use. Women planning to conceive or who may be pregnant are advised not to take this medication, and it should not be taken during pregnancy. This medication should not be administered to patients with specific genetic metabolic disorders, and caution is advised for those with a history of allergies or hypersensitivity reactions. Regular blood tests and liver and kidney function evaluations should be conducted during long-term use to detect adverse reactions early and take appropriate actions. Due to numerous interactions with other medications, especially anticoagulants, diuretics, antihypertensives, lithium, and methotrexate, it is vital to inform the doctor if such medications are being taken. Drowsiness or dizziness may occur when driving or operating machinery, so caution is necessary if these symptoms arise. In case of overdose, symptoms may include vomiting, drowsiness, and gastrointestinal bleeding, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and sealed in its original container.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• bleeding from the stomach or intestines
• ulcers
• perforation
• exfoliative dermatitis
• Stevens-Johnson syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a tightly closed container that blocks light. It is crucial to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

A hard capsule containing a yellow to pale yellow powder with a light green cap and body.

Package unit

30 capsules/bottle, 100 capsules/bottle